Global Tissue Engineering and Regeneration Market 2011–2015

March 23, 2012 - PRLog -- Commenting on the report, an analyst from Healthcare team said, “The cost of managing a number of chronic conditions of the skin, such as decubitus, has initiated a strong demand for technologies that can accelerate healing. There are an estimated 1.1 million victims with burnt skin in the US who can benefit from cell-based therapy. Moreover, it is estimated that more than 15 percent of diabetic patients are developing foot ulcers worldwide. Skin/integumentary application has been established as a technology proving ground in the Global Tissue Engineering and Regeneration market.”

According to the report, the Global Tissue Engineering and Regenerative market is experiencing an increase in mergers and acquisitions. There has been significant increase in the acquisition of small and medium-sized companies by the leading tissue engineering and regenerative medicine developers. For example, Eli Lilly & Co. has partnered with Medtronic Inc. in 2011 for treating disease with a new drug delivery system for the brain.

The report also discusses key challenges impacting this market including low awareness levels in some developing countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.

TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit http://technavio.com/content/global-tissue-engineering-an...

Follow us on Twitter @ Technavio

Media Contact:
Ludmila Berkesova
Program Manager
Technavio
8 Wimpole Street
W1G 9SP London UK
Tel: 0044 207 637 2456
Fax: 0044 845 280 2825
ludmila@technavio.com
http://www.technavio.com

# # #

KJ Public Relations is committed to providing only the best in quality news. We will not publish news articles or stories that we feel is unfit for publication through our service.